Anthem Blue Cross to update drug lists supporting commercial health plans

Effective with dates of service on and after October 1, 2018, and in accordance with Anthem Blue Cross’ (Anthem) Pharmacy and Therapeutic (P&T) process, Anthem will update its drug lists that support Commercial health plans. Updates may include changes to drug tiers or a removal of a drug.  Anthem members filling prescriptions for these medications for the first time will be impacted by these changes. 

 

Please note, this update does not apply to the Select Drug List and does not impact Medicaid or Medicare plans.

Anthem members currently using a medication that is moving to a higher tier or being removed from the drug list may remain on existing therapy with no changes to benefits.  However, providers should consider if a lower tier drug, or other drug from the updated list may be appropriate for their patients. 

 

To ensure a smooth transition and minimize member costs, providers should review these changes and consider prescribing a drug on formulary or on a lower tier, if appropriate.